Subsequent to December 31, 2022, GLAAM and Houng Ki Kim, GLAAM’s co-founder, entered into a credit agreement dated January 2, 2023, that provides for a revolving line of credit to GLAAM in an amount of KRW2,000,000,000, with interest accruing at an annual rate of 5% and with a maturity date of December 31, 2023. As of June 30, 2023, an aggregate of KRW875,469,112 was outstanding under the credit agreement.
On March 23, 2023, GLAAM issued the CB to Charm Savings Bank in an aggregate principal amount of KRW2.5 billion, with interest accruing at an annual rate of 10% and maturing on March 23, 2024. The CB is partially guaranteed by GLAAM stock held by Bio X, a related party of GLAAM. On August 21, 2023, Charm Savings Bank transferred the CB to Blooming Innovation Co. Ltd. On August 21, 2023, Blooming Innovation Co. Ltd. and GLAAM amended the CB to provide that, following the Business Combination, the CB is convertible into 217,614 Ordinary Shares. The Company is engaged in negotiations to extend the maturity date of its debt to December 31, 2024, and to allow the conversion of this debt into equity at its discretion.
On April 27, 2023, the Company entered into a loan agreement with Kyung Sook Kim for an aggregate principal amount of KRW1,500,000,000, with interest accruing at the rate of 3% per month and maturing on October 26, 2023. On May 26, 2023, a payment of KRW 250,000,000 was made. Subsequently, on May 30, 2023, an additional repayment of KRW 50,000,000 took place, leaving a remaining balance of KRW 1,200,000,000 as of the date of this prospectus. On December 4, 2023, the Company entered into an extension agreement, pursuant to which the maturity date was extended to December 29, 2023. The Company is engaged in negotiations with Kyung Sook Kim to extend the debt’s maturity date to December 31, 2024. Furthermore, discussions are ongoing with the lender regarding the conversion of debt into equity, with a significant probability that KRW 1,200,000,000 of the debt will be converted into equity shares.
The Company is presently engaged in negotiations for debt-to-equity conversions with I-MEAN Partners, Mirae Assets, and Jae-Young Kim. The conversions are for outstanding debts valued at KRW 451,000,000, KRW 200,000,000, and KRW 127,792,434, respectively.
On May 9, 2023, the Company entered into a loan agreement with Nam In Kim for an aggregate principal amount of KRW500,000,000, with interest accruing at an annual rate of 15% and maturing on June 23, 2023. The loan is secured by 170,000 GLAAM Common Shares held by Bio X. On December 4, 2023, the Company entered into an extension agreement, pursuant to which the maturity date was extended to December 29, 2023. The Company is engaged in negotiations pursuant to which the Company would repay KRW 200,000,000 of the debt on February 23, 2024, and Nam In Kim would extend the term of the remaining debt of KRW 300,000,000 until December 31, 2024.
On May 17, 2023, the Company entered into a loan agreement with Yongwoo Kim for an aggregate principal amount of KRW 300,000,000, with interest accruing at an annual rate of 5% per annum. The Company is engaged in negotiations with Yongwoo Kim, pursuant to which the Company would repay KRW 100,000,000 of the debt on February 23, 2024, and the lender would extend the remaining debt of KRW 200,000,000 until December 31, 2024. This loan remains outstanding as of the date of this prospectus.
On June 21, 2023, the Company entered into a loan agreement with Seong Ik Han for an aggregate principal amount of KRW300,000,000, with interest accruing at the rate of 1% per month and maturing on July 21, 2023. The loan is secured by 900,000 GLAAM Common Shares held by Bio X. On December 4, 2023, the Company entered into an extension agreement, pursuant to which the maturity date was extended to December 29, 2023. This loan remains outstanding as of the date of this prospectus. The newly extended maturity date has been set for February 29, 2024.
On September 1, 2023, the Company entered into a loan agreement with Yu Ha Asset Co., Ltd. for an aggregate principal amount of KRW 1,000,000,000, with interest accruing at an annual rate of 12% and maturing on November 20, 2023. On December 4, 2023, the Company entered into an extension agreement, pursuant to which the maturity date was extended to December 29, 2023. The Company is engaged in negotiations with Yu
119